Baxter International Inc. Overview
Pro stress-test →Baxter International is a leading provider of essential healthcare products and services spanning from acute hospital settings to home-based therapies. The company addresses critical needs in patient care through a diverse product portfolio including IV solutions, infusion systems, smart beds, pharmaceuticals, and surgical equipment. The company is undergoing its most significant transformation in decades, moving away from its legacy kidney care business and doubling down on high-tech medical devices.
Strategic Profile
Pro stress-test →Baxter's business model combines high-volume, low-margin consumables (like IV bags) with high-value, high-margin capital equipment (like smart beds), creating a "connected" ecosystem where Baxter devices communicate with hospital networks to improve outcomes. New CEO Andrew Hider (appointed September 2025) is implementing "Baxter GPS" (Growth and Performance System), a lean-manufacturing framework aimed at stripping out corporate bureaucracy and improving operational efficiency.
Competitive Landscape
Pro stress-test →Baxter competes in medical devices and hospital products space offering IV solutions, infusion systems, surgical equipment, smart bed systems, patient monitoring, specialty injectables, and inhaled anesthetics used across hospitals, nursing homes, ambulatory surgery centers, and patients' homes. Primary competitors include BD (medical devices/infusion systems), Medtronic (hospital devices/monitoring), Cardinal Health (distribution/devices), and B. Braun (infusion therapy products).
Industry Context
Baxter International Inc. operates in Medical Devices & Healthcare Products.
Key facts
Founded: 1931 · Headquarters: Deerfield, Illinois, US · Employees: 37,500 · Revenue: $11.2B · Market cap: $9.6B